Revolution Medicines (RVMDW) Assets (2019 - 2026)
Revolution Medicines (RVMDW) posted quarterly Assets of $2.3 billion for Q1 2026, down 4.72% year-over-year from $2.4 billion in Q1 2025, and down 4.28% quarter-over-quarter from $2.4 billion in Q4 2025.
Revolution Medicines (RVMDW) Assets (2019 - 2026) Analysis & Trends
Revolution Medicines' Assets history runs 8 years deep, the most recent figure standing at $2.3 billion for Q1 2026.
- In Q1 2026, Assets fell 4.72% year-over-year to $2.3 billion; the TTM figure through Mar 2026 stood at $2.3 billion (down 4.72% YoY), while the FY2025 annual figure was $2.4 billion, down 7.97% from the prior year.
- Assets for Q1 2026 stood at $2.3 billion, down from $2.4 billion in the prior quarter.
- The five-year high for Assets was $2.6 billion in Q4 2024, with the low at $55.9 million in Q2 2024.
- The 5-year median for Assets is $1.8 billion (2024), against an average of $1.5 billion.
- The sharpest annual moves came in 2024 and 2025: Assets plunged 94.79% in 2024, then jumped 4246.28% in 2025.
- Revolution Medicines' Assets stood at $811.9 million in 2022, then soared by 153.93% to $2.1 billion in 2023, then advanced by 24.09% to $2.6 billion in 2024, then retreated by 7.97% to $2.4 billion in 2025, then slipped by 4.28% to $2.3 billion in 2026.
- Business Quant data shows RVMDW's Assets at $2.3 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Revolution Medicines | 2.45 Bn | 2.45 Bn | - | 4.32 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Bn |
| Mar 31, 2026 | 2.25 Bn |
| Dec 31, 2025 | 2.35 Bn |
| Sep 30, 2025 | 2.25 Bn |
| Jun 30, 2025 | 2.43 Bn |
| Mar 31, 2025 | 2.37 Bn |
| Dec 31, 2024 | 2.56 Bn |
| Sep 30, 2024 | 1.76 Bn |
| Jun 30, 2024 | 55.90 Mn |
| Mar 31, 2024 | 1.91 Bn |
| Dec 31, 2023 | 2.06 Bn |
| Sep 30, 2023 | 984.23 Mn |
| Jun 30, 2023 | 1.07 Bn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 811.93 Mn |
| Sep 30, 2022 | 825.91 Mn |
| Jun 30, 2022 | 632.80 Mn |
| Mar 31, 2022 | 682.77 Mn |
| Dec 31, 2021 | 737.99 Mn |
| Sep 30, 2021 | 734.98 Mn |